Biomarkers in Diagnosing and Treatment of Acute Heart Failure
Authors:
- 3 October 2019
- journal article
- review article
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 13 (14) , 1235-1249
Abstract
Acute heart failure (AHF) is a complex disorder involving different pathophysiological pathways. In recent years, there is an increased focus on biomarkers that help with diagnosis, risk stratifica...Keywords
This publication has 127 references indexed in Scilit:
- Galectin 3 complements BNP in risk stratification in acute heart failureBiomarkers, 2012
- Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term OutcomesCirculation: Heart Failure, 2011
- Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular DiseaseCirculation: Cardiovascular Genetics, 2010
- Copeptin and risk stratification in patients with acute dyspneaCritical Care, 2010
- Epidemiology and risk profile of heart failureNature Reviews Cardiology, 2010
- Galectin-3, Cardiac Structure and Function, and Long-Term Mortality in Patients with Acutely Decompensated Heart FailureEuropean Journal of Heart Failure, 2010
- The Association of Hemoglobin A1c With Incident Heart Failure Among People Without Diabetes: The Atherosclerosis Risk in Communities StudyDiabetes, 2010
- MiR423-5p As a Circulating Biomarker for Heart FailureCirculation Research, 2010
- A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2009
- IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling systemJournal of Clinical Investigation, 2007